“…In recent years, a novel antigen delivery system consisting of non-living, non-genetically modified cell wall particles derived from the food-grade bacterium Lactococcus lactis MG1363 is described for a number of pathogens, including shigellosis ( Heine et al, 2015 ), human papillomavirus (HPV) ( Ribelles et al, 2013 ), influenza virus (H1N1) ( Saluja et al, 2010 ), porcine circovirus type 2 (PCV2) ( Qiao et al, 2019 ), hepatitis E virus (HEV) ( Gao et al, 2015 ), foot-and-mouth disease virus (FMDV) ( Cheng et al, 2019 ), severe acute respiratory syndrome coronavirus (SARS) ( Lee et al, 2006 ), and porcine reproductive and respiratory syndrome virus (PRRSV) ( Li et al, 2018 ). This novel antigen delivery system allows for the display of multiple antigens on the particle surface in the form of recombinant fusion proteins containing a heterogeneous antigen and a peptidoglycan protein anchor (PA).…”